NCT01445106View on ClinicalTrials.gov

A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 11, 2006

Primary Completion Date

May 9, 2011

Study Completion Date

May 9, 2011

Conditions
Solid Tumors
Interventions
DRUG

Nelfinavir

DRUG

Nelfinavir Mesylate

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01445106 - A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors | Biotech Hunter | Biotech Hunter